云南裕丰药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
26
NMPA:26
Drug Approvals
Fexofenadine Hydrochloride Tablets
- Product Name
- 盐酸非索非那定片
- Approval Number
- 国药准字H20080123
- Approval Date
- Feb 21, 2023
NMPA
Alendronate Sodium Tablets
- Product Name
- 阿仑膦酸钠片
- Approval Number
- 国药准字H20073959
- Approval Date
- Oct 11, 2022
NMPA
Compound Aminopyrine Phenacetin Tablets
- Product Name
- 去痛片
- Approval Number
- 国药准字H53020408
- Approval Date
- Apr 22, 2020
NMPA
l,Aminophenazone Caffeine and Chlorphenamine Malea
- Product Name
- 酚氨咖敏片
- Approval Number
- 国药准字H53021866
- Approval Date
- Apr 22, 2020
NMPA
Compound Aspirin Tablets
- Product Name
- 复方乙酰水杨酸片
- Approval Number
- 国药准字H53021635
- Approval Date
- Apr 22, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found